跳至主要内容
临床试验/NCT02080013
NCT02080013已完成不适用

Prospective, Randomized Study of Endovenous Segmental Radiofrequency Versus 1320 nm Laser Ablation for the Treatment of Great Saphenous Vein Reflux (RVLAb Study)

Ain Shams University0 个研究点目标入组 5 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5
主要终点
Number of Participants with Adverse Events as a Measure of Safety and Tolerability

研究概览

简要总结

our aim is to compare early outcomes following EVL 1320 nm and segmental RF in a randomized study.

详细描述

Endovenous Radiofrequency versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 18 and 60 years with incompetent GSVs documented on duplex ultrasound (US; B-mode and color Doppler imaging) were eligible

排除标准

  • Exclusion criteria consisted of:
  • Current deep vein thrombosis (DVT)
  • Thrombus in the vein of interest
  • Previous GSV treatment
  • Pregnancy
  • Known malignancy
  • Significant arterial disease (ankle : brachial pressure index below 0•8)
  • Use of anticoagulant medication.

结局指标

主要结局

Number of Participants with Adverse Events as a Measure of Safety and Tolerability

时间窗: 30 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hossam M. Saleh

A. Prof vascular surgery

Ain Shams University

相似试验